See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2020_Propanc_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001517681')"} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 91,132 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,417 |
| 3 | remainder_Assets | 2,103 |
| 4 | LiabilitiesCurrent | 4,402,888 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 28,062 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,326,350 |
| 9 | ResearchAndDevelopmentExpense | 260,335 |
| 10 | remainder_Expenses | -115,437 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -3,259,059 |
| 13 | remainder_ComprehensiveNetIncome | 709,069 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 101,652 |
| 1 | Liabilities | 4,402,888 |
| 2 | Expenses | 2,499,310 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -4,301,236 |
| 5 | NetIncome | -5,758,369 |
| 6 | ComprehensiveNetIncome | -5,403,834 |
| 7 | BaseVar | 5,485,989 |
| 8 | EconomicCapitalRatio | -5.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
